Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Bartolini, Francesca

Columbia University Health Sciences
United States

Investigating the Pathogenic Role of Tubulin Post-translational Modifications in CIPN 5R01CA279401-02 Rachel Altshuler, Ph.D.
Barton, Jennifer Kehlet

University Of Arizona
United States

Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers 5R01CA260399-04 Guillermo Marquez, Ph.D.
Basu, Partha

International Agency For Res On Cancer
United States

A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs 3R37CA275824-03S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Bedrosian, Isabelle

University Of Tx Md Anderson Can Ctr
United States

Chimeric RNA driven neopeptide vaccine for prevention of breast cancer in germline BRCA1/2 carriers 1UG3CA290454-01A1 Altaf Mohammed, Ph.D.
Beretta, Laura

University Of Tx Md Anderson Can Ctr
United States

Early Detection of Hepatocellular Carcinoma 5R01CA195524-09 Matthew Young, Ph.D.
Bergan, Raymond C.

University Of Nebraska Medical Center
United States

Preventing invasive prostate cancer 3R01CA276846-03S1 John Clifford, Ph.D.
Bertozzi, Carolyn

Stanford University
United States

Chemical Glycoproteomics 5R01CA200423-22 Guillermo Marquez, Ph.D.
Bettegowda, Chetan

Johns Hopkins University
United States

Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid 5R37CA230400-07 Sidney Fu, M.D.
Bhatt, Vijaya Raj

University Of Nebraska Medical Center
United States

Aging trajectories and outcomes of older adults with acute myeloid leukemia 5R37CA276928-03 Brennan Streck, Ph.D., RN, M.P.H.
Bhatt, Vijaya Raj

University Of Nebraska Medical Center
United States

Aging trajectories and outcomes of older adults with acute myeloid leukemia 5R37CA276928-03 Brennan Streck, Ph.D., RN, M.P.H.
Bissonnette, Bruce Marc

University Of Chicago
United States

A non-invasive blood test for multi-cancer detection and determination of tissue of origin preceding overt cancer diagnosis 1U01CA297685-01 Claire Zhu, Ph.D.
Blanke, Charles D.

Oregon Health & Science University
United States

SWOG NCORP Research Base 3UG1CA189974-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Blanke, Charles D.

Oregon Health & Science University
United States

SWOG NCORP Research Base 3UG1CA189974-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Blanke, Charles D.

Oregon Health & Science University
United States

SWOG NCORP Research Base 3UG1CA189974-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Blanke, Charles D.

Oregon Health & Science University
United States

SWOG NCORP Research Base 3UG1CA189974-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.